Akizuki S, Ohnishi A, Kotani K, Sudo K (2004)
Genetic and immunological analyses of patients with increased serum butyrylcholinesterase activity and its C5 variant form
Clinical Chemistry & Laboratory Medicine 42: 991

Akizuki S, Sudo K, Abe M, Abe I, Nakajima T, Ohnishi A, Maekawa M (1999)
[Dibucaine number (DN) and fluoride number (FN) of L330 I mutant recombinant cholinesterase by use of various substrates]
Rinsho Byori 47: 479

Dey DC, Maekawa M, Sudo K, Kanno T (1998)
Butyrylcholinesterase genes in individuals with abnormal inhibition numbers and with trace activity: one common mutation and two novel silent genes
Annals of Clinical Biochemistry 35: 302

Maekawa M, Sudo K, Dey DC, Ishikawa J, Izumi M, Kotani K, Kanno T (1997)
Genetic mutations of butyrylcholine esterase identified from phenotypic abnormalities in Japan
Clinical Chemistry 43: 924

Sudo K, Maekawa M, Akizuki S, Magara T, Ogasawara H, Tanaka T (1997)
Human butyrylcholinesterase L330I mutation belongs to a fluoride-resistant gene, by expression in human fetal kidney cells
Biochemical & Biophysical Research Communications 240: 372

Sudo K, Maekawa M, Kanno T, Akizuki S, Magara T (1996)
Three different point mutations in the butyrylcholinesterase gene of three Japanese subjects with a silent phenotype: possible Japanese type alleles
Clinical Biochemistry 29: 165

Maekawa M, Sudo K, Kanno T, Kotani K, Dey DC, Ishikawa J, Izumi M, Etoh K (1995)
Genetic basis of the silent phenotype of serum butyrylcholinesterase in three compound heterozygotes
Clinica Chimica Acta 235: 41